Finally, PD-L1 expression is constitutively elevated in KRAS G13D but not in NRAS Q61K or MEK1 Q56P A375 cells, pointing to a possible role for immune checkpoint inhibition in melanomas carrying this specific biomarker. This evidence concerns the gene KRAS and melanoma.